发明名称 |
Use of the compound 2-methoxyphenyl-1-methyl-5P-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an antiinflammatory drug with prevention of gastric hypersecretion and renal impairment |
摘要 |
<p>The present invention relates to the use of the compound 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate (known also as amtolmetin guacyl and indicated in the present description also as MED 15) for the production of a NSAID for treating an inflammatory pathological condition with effect of prevention of NSAID-related hydrochloric acid hypersecretion, wherein in order to show its gastro-protective effect same compound has to be administered on empty stomach and without a simultaneous assumption of H1 receptor inhibiting drugs.</p> |
申请公布号 |
EP1310250(A1) |
申请公布日期 |
2003.05.14 |
申请号 |
EP20020078447 |
申请日期 |
1997.08.08 |
申请人 |
MEDOSAN RICERCA S.R.L.;SIGMA-TAU INDUSTRIEFARMACEUTICHE RIUNITE S.P.A. |
发明人 |
ANZALONE, SERGIO |
分类号 |
A61K31/40;A61P29/00;(IPC1-7):A61K31/40 |
主分类号 |
A61K31/40 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|